Antihemophilic Factor (Recombinant) (Advate) and Valrubicin
Determining the interaction of Antihemophilic Factor (Recombinant) (Advate) and Valrubicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Advate)-Valrubicin Intravesical
- Antihemophilic Factor (Recombinant) (Advate)-Valsartan
- Antihemophilic Factor (Recombinant) (Advate)-Valsartan and Hydrochlorothiazide
- Antihemophilic Factor (Recombinant) (Advate)-Valsartan Capsules
- Antihemophilic Factor (Recombinant) (Advate)-Valsartan Tablets
- Antihemophilic Factor (Recombinant) (Advate)-Valstar
- Valrubicin-Antihemophilic Factor (Recombinant) (Afstyla)
- Valrubicin-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Valrubicin-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Valrubicin-Antihemophilic Factor (Recombinant) (Nuwiq)
- Valrubicin-Antihemophilic Factor (Recombinant) (Recombinate)
- Valrubicin-Antihemophilic Factor (Recombinant) (Xyntha)